These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1690659

  • 21. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J, Chonn A, Hertig S, French LE.
    J Immunol; 1993 Aug 15; 151(4):2159-65. PubMed ID: 8345200
    [Abstract] [Full Text] [Related]

  • 22. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL, Sodetz JM.
    Mol Immunol; 2007 Feb 15; 44(5):960-5. PubMed ID: 16624411
    [Abstract] [Full Text] [Related]

  • 23. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA, Tartanian AB, Hammer CH, Schweinle JE.
    J Immunol; 1989 Jun 15; 142(12):4450-7. PubMed ID: 2656866
    [Abstract] [Full Text] [Related]

  • 24. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
    Tschopp J, Podack ER, Müller-Eberhard HJ.
    J Immunol; 1985 Jan 15; 134(1):495-9. PubMed ID: 3964819
    [Abstract] [Full Text] [Related]

  • 25. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ.
    Biochem Soc Symp; 1985 Jan 15; 50():235-46. PubMed ID: 2428370
    [Abstract] [Full Text] [Related]

  • 26. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER, Tschoop J, Müller-Eberhard HJ.
    J Exp Med; 1982 Jul 01; 156(1):268-82. PubMed ID: 6177822
    [Abstract] [Full Text] [Related]

  • 27. Membrane attack complex of complement in dermatitis herpetiformis.
    Dahl MV, Falk RJ, Carpenter R, Michael AF.
    Arch Dermatol; 1985 Jan 01; 121(1):70-2. PubMed ID: 3881089
    [Abstract] [Full Text] [Related]

  • 28. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW, Shin ML.
    J Immunol; 1984 Oct 01; 133(4):2133-7. PubMed ID: 6470486
    [Abstract] [Full Text] [Related]

  • 29. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.
    Patarakul K, Cole MF, Hughes CA.
    Microb Pathog; 1999 Jul 01; 27(1):25-41. PubMed ID: 10371707
    [Abstract] [Full Text] [Related]

  • 30. A unique epitope exposed in native complement component C9 and hidden in the terminal SC5b-9 complex enables selective detection and quantification of non-activated C9.
    Mollnes TE, Tschopp J.
    J Immunol Methods; 1987 Jun 26; 100(1-2):215-21. PubMed ID: 2439601
    [Abstract] [Full Text] [Related]

  • 31. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
    Ramm LE, Whitlow MB, Mayer MM.
    J Immunol; 1985 Apr 26; 134(4):2594-9. PubMed ID: 2579147
    [Abstract] [Full Text] [Related]

  • 32. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L, Morris CA, Sheehan MC, Charlesworth JA, Pussell BA.
    Clin Exp Immunol; 1993 Apr 26; 92(1):114-9. PubMed ID: 7682159
    [Abstract] [Full Text] [Related]

  • 33. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP, Imagawa DK, Dankert JR, Ramm LE.
    J Immunol; 1986 May 01; 136(9):3402-6. PubMed ID: 3514758
    [Abstract] [Full Text] [Related]

  • 34. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK, Johnson RC, Dalmasso AP.
    J Immunol; 1991 Jun 01; 146(11):3964-70. PubMed ID: 2033266
    [Abstract] [Full Text] [Related]

  • 35. Quantitation of activation of the human terminal complement pathway by ELISA.
    Sanders ME, Schmetz MA, Hammer CH, Frank MM, Joiner KA.
    J Immunol Methods; 1985 Dec 27; 85(2):245-56. PubMed ID: 2416846
    [Abstract] [Full Text] [Related]

  • 36. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites.
    MacKay SL, Dankert JR.
    J Immunol; 1990 Nov 15; 145(10):3367-71. PubMed ID: 2230122
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis.
    Pilzer D, Fishelson Z.
    Int Immunol; 2005 Sep 15; 17(9):1239-48. PubMed ID: 16091382
    [Abstract] [Full Text] [Related]

  • 39. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM, Schönermark S, Roelcke D.
    J Clin Invest; 1987 Jul 15; 80(1):7-12. PubMed ID: 3597779
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI, Packman CH, Leddy JP.
    J Clin Invest; 1983 Apr 15; 71(4):795-808. PubMed ID: 6403580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.